European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 232-235, May 2009

Glucoregulation in type 2 diabetes: The lower the better? Glycosylated HbA1c of 6.5% seems to be the limit

  • I.M. Jazet

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of General Internal Medicine, C4-R-73, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Tel.: +31 71 5127227; fax: +31 71 5248140.
    • ,
  • A.E. Meinders

Department of General Internal Medicine, C4-R-73, Leiden University Medical Center, Leiden, The Netherlands

Received 10 July 2008; accepted 1 August 2008. published online 15 September 2008.

Keywords: ACCORD, ADVANCE, HbA1c, Tight glucoregulatin, Cardiovascular risk

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(08)00245-8

doi:10.1016/j.ejim.2008.08.002

European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 232-235, May 2009

Article Tools